Digital Diabetes Management Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Digital Diabetes Management Market By Product (Smart glucose meter, Continuous blood glucose monitoring system, Smart insulin pens, Smart insulin pumps, and apps), By App (Digital diabetes management app and Weight & diet management app), By Device type (Handheld device and Wearable device), By End user (Self/Home healthcare, Hospitals & specialty diabetes clinics, and Academic & Research institutes) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Digital Diabetes Management Market was valued at USD 7.3 billion in 2021 and is anticipated to grow at US$ 20.10 billion by 2028 recording a CAGR of 23.9% during the forecast period 2022-2028. Patients can use the digital diabetes management system to improve self-management and control of their condition. One of the key obstacles in managing diabetes is lowering blood glucose levels and maintaining them, which drives up use of these systems. Digital involvement can help individuals with diabetes types 1 and 2 get the care they need. Diabetes monitoring hardware, mobile applications, and big data healthcare cloud computing infrastructure make up digital diabetes devices. The term “smart glucose monitor” refers to a wireless blood glucose monitor that measures and transmits blood glucose data to an iOS or Android mobile device. The digital diabetes management market is being driven by the availability of many apps on web-based app stores that can assist patients monitor their blood glucose levels, rising technical breakthroughs and innovations in the sector, and the global growth in diabetes prevalence. The ability of patients to address their health issues by connecting with their healthcare team and sharing data, as well as the growing demand for a digital ecosystem of data-driven tools that can connect patients and their care team for better diabetes management, are driving the growth of the market. The digital diabetes management market is influenced by the increased acceptance of cloud-based enterprise solutions for diabetes management, the advent of digital platforms, the adoption of mobile apps for diabetes management, and the widespread usage of smartphones among consumers. Furthermore, the market is influenced favourably by the growing elderly population, rising disease incidence, changing lifestyles and poor eating habits, rising obesity population, increased awareness, and increased healthcare spending. Strict regulations related to the approval of applications and devices, however, can impede market development.Stress, sedentary lifestyles, poor diets, and obesity are the main risk factors for diabetes. Physiological changes due to ageing are also a major contributor to the risk of diabetes. For instance, the global population aged 60 and over grew from 962 million in 2017 to 1.9 billion in 2045, according to the World Population Aging Report 2017. Nevertheless, the prevalence of diabetes for people over the age of 60 in 2017 is 18.5%. The number of elderly people with diabetes is projected to grow to around 177.4 million in 2017 and to 337.8 million in 2045. The rising geriatric population, coupled with increasing population exposure to key risk factors, is therefore expected to drive demand across major markets for digital diabetes management solutions.

 


Digital Diabetes Management Market

MARKET SUMMARY
-
23.9%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 23.9%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Digital Diabetes Management Market

  • The report on global digital diabetes management market gives historical, current and future market size (US$ Bn) on the basis of product, app, device type, end user, and geography.
  • This study analyses the global digital diabetes management market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market.
  • In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across region and consumer unmet needs.
  • On June 15, 2020, Abbott Laboratories has received FDA clearance for its new continuous glucose meter, which is Freestyle Libre2. This device is another challenger in the growing market for CGM.
  • On February 19, 2020, Dexcom collaborates with DreaMed to couple Dexcom continuous glucose monitors, and the DreaMed Advisor is a digital solution that generates insulin delivery by investigating information from continuous glucose monitoring self-monitoring blood glucose and insulin delivery devices.
  • On April 30, 2020. Roche Diagnostics has announced free access for mySugr Pro app in assisting millions of people who have diabetes to maintain their personalized daily diabetes during COVID-19 crisis.
Market Key Players
  • Medtronic
  • Braun
  • Dexcom
  • Abbott Laboratories
  • Roche Diagnostics
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care
  • LifeScan
  • AgaMatrix
Growth

Digital Diabetes Management Market

The rising geriatric pool, government initiatives, self-care demand, and high diabetes prevalence are major factors driving market growth. Market growth has been powered by a growing number of product launches in conjunction with the integration of artificial intelligence and data analytics. Increased understanding of preventive care and the prevalence of obesity may lead to a greater rise in the demand for digital applications for diabetes management.


North-America Got Significant Share

Digital Diabetes Management Market

Global digital diabetes management market report provide a comprehensive outlook on digital diabetes management worldwide with specific focus on key region such as North America, Europe, Asia Pacific, Latin America and MEA. Because of the adoption of technologically advanced technologies, favorable government schemes, and initiatives to support public health, the North America is touted to lead the global digital diabetes management market until the end of the forecast period. Diabetes awareness and mobile application creation can drive regional market demand. Regional development is marked by mergers, acquisitions, and the introduction of new goods. For example, for the creation of a digital health platform, Abbott and Dexcom have agreed to join hands with Insulet. Because of product launches and combination indicates the introduction of next-generation BGM systems in the area, Asia-Pacific is predicted to grow at the quickest rate during the projection period of 2021 to 2027.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Digital Diabetes Management Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Digital Diabetes Management Market Introduction
2.1. Global Digital Diabetes Management Market – Taxonomy
2.2. Global Digital Diabetes Management Market –Definitions
2.2.1. By Product & Services
2.2.2. By Type
2.2.3. By End User
2.2.4. By Region
3. Global Digital Diabetes Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Digital Diabetes Management Market Dynamics – Factors Impact Analysis
4. Global Digital Diabetes Management Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Digital Diabetes Management Market Forecast, By Product & Services, 2017 – 2021 and Forecast, 2022 – 2028
5.1. Devices
5.1.1.  Smart Glucose Meters
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Continuous Glucose Monitoring Systems
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Smart Insulin Pens
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
5.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Digital Diabetes Management Apps
5.2.1. Diabetes and Blood Glucose Tracking Apps
5.2.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Weight and Diet Management Apps
5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.3. Data Management Software and Platforms
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Services
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Digital Diabetes Management Market Forecast, By Type, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Wearable Devices
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Handheld Devices
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Digital Diabetes Management Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Individual/Home Healthcare
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Hospitals and Specialty Diabetes Clinics
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Academic and Research Institutes
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Digital Diabetes Management Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Digital Diabetes Management Market – Opportunity Analysis Index, By Product & Services, By Type, By End User, and Region, 2022 – 2028
9. North America Digital Diabetes Management Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
9.1. Product & Services Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Devices
9.1.1.1. Smart Glucose Meters
9.1.1.2. Continuous Glucose Monitoring Systems
9.1.1.3. Smart Insulin Pens
9.1.1.4. Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
9.1.2. Digital Diabetes Management Apps
9.1.2.1. Diabetes and Blood Glucose Tracking Apps
9.1.2.2. Weight and Diet Management Apps
9.1.3. Data Management Software and Platforms
9.1.4. Services
9.2. Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Wearable Devices
9.2.2. Handheld Devices
9.3. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Individual/Home Healthcare
9.3.2. Hospitals and Specialty Diabetes Clinics
9.3.3. Academic and Research Institutes
9.3.4. Others
9.4. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Digital Diabetes Management Market – Opportunity Analysis Index, By Product & Services, By Type, By End User, and Country, 2022 – 2028
9.6. North America Digital Diabetes Management Market Dynamics – Trends
10. Europe Digital Diabetes Management Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
10.1. Product & Services Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Devices
10.1.1.1. Smart Glucose Meters
10.1.1.2. Continuous Glucose Monitoring Systems
10.1.1.3. Smart Insulin Pens
10.1.1.4. Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
10.1.2. Digital Diabetes Management Apps
10.1.2.1. Diabetes and Blood Glucose Tracking Apps
10.1.2.2. Weight and Diet Management Apps
10.1.3. Data Management Software and Platforms
10.1.4. Services
10.2. Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Wearable Devices
10.2.2. Handheld Devices
10.3. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Individual/Home Healthcare
10.3.2. Hospitals and Specialty Diabetes Clinics
10.3.3. Academic and Research Institutes
10.3.4. Others
10.4. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. France
10.4.2. Germany
10.4.3. U.K.
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Rest of Europe
10.5. Europe Digital Diabetes Management Market – Opportunity Analysis Index, By Product & Services, By Type, By End User, and Country, 2022 – 2028
10.6. Europe Digital Diabetes Management Market Dynamics – Trends
11. Asia Pacific Digital Diabetes Management Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
11.1. Product & Services Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Devices
11.1.1.1. Smart Glucose Meters
11.1.1.2. Continuous Glucose Monitoring Systems
11.1.1.3. Smart Insulin Pens
11.1.1.4. Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
11.1.2. Digital Diabetes Management Apps
11.1.2.1. Diabetes and Blood Glucose Tracking Apps
11.1.2.2. Weight and Diet Management Apps
11.1.3. Data Management Software and Platforms
11.1.4. Services
11.2. Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Wearable Devices
11.2.2. Handheld Devices
11.3. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Individual/Home Healthcare
11.3.2. Hospitals and Specialty Diabetes Clinics
11.3.3. Academic and Research Institutes
11.3.4. Others
11.4. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. Australia and New Zealand
11.4.4. India
11.4.5. Philippines
11.4.6. Rest of Asia Pacific
11.5. Asia Pacific Digital Diabetes Management Market – Opportunity Analysis Index, By Product & Services, By Type, By End User, and Country, 2022 – 2028
11.6. Asia Pacific Digital Diabetes Management Market Dynamics – Trends
12. Latin America Digital Diabetes Management Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
12.1. Product & Services Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Devices
12.1.1.1. Smart Glucose Meters
12.1.1.2. Continuous Glucose Monitoring Systems
12.1.1.3. Smart Insulin Pens
12.1.1.4. Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
12.1.2. Digital Diabetes Management Apps
12.1.2.1. Diabetes and Blood Glucose Tracking Apps
12.1.2.2. Weight and Diet Management Apps
12.1.3. Data Management Software and Platforms
12.1.4. Services
12.2. Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Wearable Devices
12.2.2. Handheld Devices
12.3. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Individual/Home Healthcare
12.3.2. Hospitals and Specialty Diabetes Clinics
12.3.3. Academic and Research Institutes
12.3.4. Others
12.4. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of LATAM
12.5. Latin America Digital Diabetes Management Market – Opportunity Analysis Index, By Product & Services, By Type, By End User, and Country, 2021 – 2027
12.6. Latin America Digital Diabetes Management Market – Trends
13. Middle East and Africa Digital Diabetes Management Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
13.1. Product & Services Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Devices
13.1.1.1. Smart Glucose Meters
13.1.1.2. Continuous Glucose Monitoring Systems
13.1.1.3. Smart Insulin Pens
13.1.1.4. Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
13.1.2. Digital Diabetes Management Apps
13.1.2.1. Diabetes and Blood Glucose Tracking Apps
13.1.2.2. Weight and Diet Management Apps
13.1.3. Data Management Software and Platforms
13.1.4. Services
13.2. Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Wearable Devices
13.2.2. Handheld Devices
13.3. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Individual/Home Healthcare
13.3.2. Hospitals and Specialty Diabetes Clinics
13.3.3. Academic and Research Institutes
13.3.4. Others
13.4. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Turkey
13.4.2. Saudi Arabia
13.4.3. GCC Countries
13.4.4. Egypt
13.4.5. Others
13.5. Middle East and Africa  Digital Diabetes Management Market – Opportunity Analysis Index, By Product & Services, By Type, By End User, and Country, 2021 – 2027
13.6. Middle East and Africa Digital Diabetes Management Market – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Medtronic (Ireland)
14.2.2. B. Braun (Germany)
14.2.3. Dexcom (US)
14.2.4. Abbott Laboratories (US)
14.2.5. Roche Diagnostics (Switzerland)
14.2.6. Insulet Corporation (US)
14.2.7. Tandem Diabetes Care (US)
14.2.8. Ascensia Diabetes Care (Switzerland)
14.2.9. LifeScan (US)
14.2.10. Tidepool (US)
14.2.11. AgaMatrix (US)
14.2.12. Glooko Inc. (US)
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Medtronic
  • Braun
  • Dexcom
  • Abbott Laboratories
  • Roche Diagnostics
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care
  • LifeScan
  • AgaMatrix

Description

Digital Diabetes Management Market was valued at USD 7.3 billion in 2021 and is anticipated to grow at US$ 20.10 billion by 2028 recording a CAGR of 23.9% during the forecast period 2022-2028. Patients can use the digital diabetes management system to improve self-management and control of their condition. One of the key obstacles in managing diabetes is lowering blood glucose levels and maintaining them, which drives up use of these systems. Digital involvement can help individuals with diabetes types 1 and 2 get the care they need. Diabetes monitoring hardware, mobile applications, and big data healthcare cloud computing infrastructure make up digital diabetes devices. The term “smart glucose monitor” refers to a wireless blood glucose monitor that measures and transmits blood glucose data to an iOS or Android mobile device. The digital diabetes management market is being driven by the availability of many apps on web-based app stores that can assist patients monitor their blood glucose levels, rising technical breakthroughs and innovations in the sector, and the global growth in diabetes prevalence. The ability of patients to address their health issues by connecting with their healthcare team and sharing data, as well as the growing demand for a digital ecosystem of data-driven tools that can connect patients and their care team for better diabetes management, are driving the growth of the market. The digital diabetes management market is influenced by the increased acceptance of cloud-based enterprise solutions for diabetes management, the advent of digital platforms, the adoption of mobile apps for diabetes management, and the widespread usage of smartphones among consumers. Furthermore, the market is influenced favourably by the growing elderly population, rising disease incidence, changing lifestyles and poor eating habits, rising obesity population, increased awareness, and increased healthcare spending. Strict regulations related to the approval of applications and devices, however, can impede market development.Stress, sedentary lifestyles, poor diets, and obesity are the main risk factors for diabetes. Physiological changes due to ageing are also a major contributor to the risk of diabetes. For instance, the global population aged 60 and over grew from 962 million in 2017 to 1.9 billion in 2045, according to the World Population Aging Report 2017. Nevertheless, the prevalence of diabetes for people over the age of 60 in 2017 is 18.5%. The number of elderly people with diabetes is projected to grow to around 177.4 million in 2017 and to 337.8 million in 2045. The rising geriatric population, coupled with increasing population exposure to key risk factors, is therefore expected to drive demand across major markets for digital diabetes management solutions.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX